Your shopping cart is currently empty

KOR/DOR agonist 2 is an agonist of the KOR and DOR opioid receptors, with Ki values of 0.14 nM and 0.93 nM, respectively. It exhibits significant antinociceptive effects and can cross the blood-brain barrier.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | KOR/DOR agonist 2 is an agonist of the KOR and DOR opioid receptors, with Ki values of 0.14 nM and 0.93 nM, respectively. It exhibits significant antinociceptive effects and can cross the blood-brain barrier. |
| Targets&IC50 | δ opioid receptor:0.2 nM (Ki), κ Opioid Receptor:0.14 nM (Ki), μ opioid receptor:0.93 nM (Ki) |
| In vitro | KOR/DOR agonist 2 (Compound 21) binds to MOR with sub-nanomolar affinity, showing a K i value of 0.20 nM. In the [35S]-GTPγS binding assay, KOR/DOR agonist 2 exhibits functional activity at KOR, MOR, and DOR, with EC 50 values of 0.04 nM, 0.58 nM, and 1.28 nM, respectively. |
| In vivo | At a dosage of 0.1 mg/kg administered subcutaneously, KOR/DOR agonist 2 demonstrates significant antinociceptive effects in the warm water tail immersion test. |
| Formula | C28H32N2O5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.